Josh Johnson met with Dr. James Andrews, who advised the Blue Jays to shut down the injured right-hander for the remainder of the season. However, the good news is that Dr. Andrews also determined that Johnson doesn’t need surgery on the strained forearm that’s sidelined him for the past three weeks.
Toronto acquired Johnson as part of the blockbuster deal with the Marlins this offseason and the one-time ace hoped to stay healthy and put together a big season with free agency right around the corner. Instead he made just 16 starts with a 6.20 ERA and more healthy problems, with Gregor Chisholm of MLB.com writing that the Blue Jays probably won’t even make him the $14 million qualifying offer necessary to receive draft pick compensation if he signs elsewhere.
If healthy he’s without question one of the best free agent pitchers available this offseason, but “if healthy” has forever been a question mark with Johnson and he may have to settle for a one-year deal at age 30.
Jon Morosi of MLB Network reports that the Yankees and Mariners are both expressing interest in Blue Jays starter J.A. Happ.
Happ is posting a 3.48 ERA and a 94/25 K/BB ratio in 82.2 innings across 14 starts and has been stingy with the hits as well. Between that, the Blue Jays’ lack of contention and the fact that Happ is in the walk year of his three-year, $36 million deal, all signs point to the Jays trading them.
In normal circumstances you might not expect the Jays to make a trade with the Yankees, but at this point it sort of doesn’t matter, does it? It’s not like Happ in New York on a couple month rental will impact the 2018 Jays too much. And, given his pending free agency, it’s not extraordinarily likely that he’d haunt the Jays from the Bronx long term either.
There’s not a ton of elite pitching currently available, but as the trade deadline approaches — a little over a month to go on that score — the talk about Happ, Cole Hamels, Francisco Liriano and others will heat up. Figure the Yankees will be linked with any and all available starters.